Response to: 'Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Carbillon .
作者信息
Konig Maximilian F, Gianfrancesco Milena, Yazdany Jinoos, Robinson Philip C
机构信息
Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
出版信息
Ann Rheum Dis. 2021 Apr;80(4):e55. doi: 10.1136/annrheumdis-2020-217990. Epub 2020 May 31.
Abstract
摘要
相似文献
1
Response to: 'Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Carbillon .
Ann Rheum Dis. 2021 Apr;80(4):e55. doi: 10.1136/annrheumdis-2020-217990. Epub 2020 May 31.
2
Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Mathian .
Ann Rheum Dis. 2022 Nov;81(11):e216. doi: 10.1136/annrheumdis-2020-218778. Epub 2020 Aug 28.
3
Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'.
Ann Rheum Dis. 2023 Oct;82(10):e215. doi: 10.1136/annrheumdis-2020-219648. Epub 2021 Jan 15.
4
Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'.
Ann Rheum Dis. 2023 Nov;82(11):e225. doi: 10.1136/annrheumdis-2021-220410. Epub 2021 Apr 21.
5
Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'.
Ann Rheum Dis. 2021 Mar;80(3):e33. doi: 10.1136/annrheumdis-2020-217827. Epub 2020 May 29.
6
Response to: 'Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine by Mathian ' by Notz .
Ann Rheum Dis. 2022 Nov;81(11):e217. doi: 10.1136/annrheumdis-2020-218795. Epub 2020 Nov 25.
7
Response to: 'COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine' by Teh .
Ann Rheum Dis. 2021 May;80(5):e70. doi: 10.1136/annrheumdis-2020-218173. Epub 2020 Jul 31.
8
Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.
Ann Rheum Dis. 2021 Apr;80(4):e54. doi: 10.1136/annrheumdis-2020-217847. Epub 2020 May 31.
9
Response to: 'Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour .
Ann Rheum Dis. 2021 Mar;80(3):e34. doi: 10.1136/annrheumdis-2020-217875. Epub 2020 May 29.
10
Response to: 'Treatment of systemic lupus erythematosus: don't forget hydroxychloroquine' by Michaud .
Ann Rheum Dis. 2020 Oct;79(10):e134. doi: 10.1136/annrheumdis-2019-215817. Epub 2019 Jul 11.
引用本文的文献
1
Rheumatic Musculoskeletal Diseases and COVID-19 A Review of the First 6 Months of the Pandemic.
Front Med (Lausanne). 2020 Oct 9;7:562142. doi: 10.3389/fmed.2020.562142. eCollection 2020.
本文引用的文献
1
Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.
Ann Rheum Dis. 2021 Apr;80(4):e54. doi: 10.1136/annrheumdis-2020-217847. Epub 2020 May 31.
2
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Ann Rheum Dis. 2020 Jul;79(7):859-866. doi: 10.1136/annrheumdis-2020-217871. Epub 2020 May 29.
3
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.
Ann Rheum Dis. 2020 Oct;79(10):1386-1388. doi: 10.1136/annrheumdis-2020-217690. Epub 2020 May 7.
4
2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.
Arthritis Rheumatol. 2020 Apr;72(4):529-556. doi: 10.1002/art.41191. Epub 2020 Feb 23.
5
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome.
Ann Rheum Dis. 2017 Mar;76(3):476-485. doi: 10.1136/annrheumdis-2016-209770. Epub 2016 Jul 25.
6
Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus.
Lupus. 2015 Feb;24(2):210-7. doi: 10.1177/0961203314555352. Epub 2014 Oct 10.
7
Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort.
Ann Rheum Dis. 2009 Feb;68(2):238-41. doi: 10.1136/ard.2008.093013. Epub 2008 Sep 9.
8
Hydroxychloroquine in lupus pregnancy.
Arthritis Rheum. 2006 Nov;54(11):3640-7. doi: 10.1002/art.22159.
9
Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study.
Lupus. 2001;10(6):401-4. doi: 10.1191/096120301678646137.
Zotero 插件